| Bioactivity | Enlicitide chloride is a potent PCSK9 antagonist. Enlicitide chloride can be used for research of cardiovascular disease, e.g. atherosclerosis, hypercholesterolemia, coronary heart disease, metabolic syndrome, acute coronary syndrome, or related cardiovascular disease and cardiometabolic conditions[1][2]. |
| Name | Enlicitide chloride |
| CAS | 2407527-16-4 |
| Sequence | Ala-{Dpr}-Phe-Trp-Pro-Thr-Tyr-Pro(Covalent bridge:Phe3-Pro5,Ala1-Trp4,Trp4-Pro8,Ala1-Pro8,D-Dpr2) |
| Shortening | A-{ Dpr}-FWPTYP(Covalent bridge:Phe3-Pro5,Ala1-Trp4,Trp4-Pro8,Ala1-Pro8,D-Dpr2) |
| Formula | C82H110ClFN14O15 |
| Molar Mass | 1586.29 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ding FX, et al. Preparation of cyclic peptides as PCSK9 antagonist compounds: World Intellectual Property Organization, WO2019246349. 2019-12-26. [2]. WHO Drug Information-World Health Organization (WHO). |
Enlicitide chloride
CAS: 2407527-16-4 F: C82H110ClFN14O15 W: 1586.29
Enlicitide chloride is a potent PCSK9 antagonist. Enlicitide chloride can be used for research of cardiovascular disease
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.